Lipocine's (LPCN) Price Target Raised to $15 at Canaccord Genuity
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Canaccord Genuity maintained a Buy rating on Lipocine Inc (NASDAQ: LPCN) and raised its price target to $15.00 (from $6.00).
Shares of Lipocine Inc closed at $5.54 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Cowen Downgrades Under Armour, Inc. (UA) to Market Perform
- Graphic Packaging (GPK) PT, Estimates Trimmed at Jefferies Post Q3
- Asbury Automotive Group (ABG) PT Lowered to $55 at Jefferies
Create E-mail Alert Related CategoriesAnalyst PT Change
Related EntitiesCanaccord Genuity
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!